Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05726942 · ClinicalTrials.gov registry record · NA
Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
A NA study of Overweight and Obesity, sponsored by San Diego State University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05726942: Recruiting NA study of Overweight and Obesity, sponsored by San Diego State University.
NCT05726942 is a NA study of Overweight and Obesity that is actively recruiting participants, run by San Diego State University. The registered enrollment target is 30 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05726942, a NA study of Overweight and Obesity, is actively recruiting participants, sponsored by San Diego State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes in patients with overweight and obesity. This study will involve a 6-month long commitment where participants will be expected to use an mHealth app daily, weigh themselves and check their fasting blood glucose levels every morning.
Primary Outcome
Determine if the mhealth app is an effective weight loss modality compared to standard weight loss program (control) Outcome measure will be body weight in kg
Conditions Studied
Interventions
- OTHER Healthi
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT05726942 shows while recruiting
NCT05726942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which Healthi is the first listed.
NCT05726942 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05726942 about?
NCT05726942 is a clinical study titled "Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity". The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes in patients with overweight and obesity. This study will involve a 6-month long commitment where participants will be expected to use an mHealth app daily, weigh themselves and chec...
What is the current status of trial NCT05726942?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-01. Estimated completion is 2028-01-31.
What conditions does trial NCT05726942 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT05726942?
The interventions under investigation include: Healthi (OTHER).
Who is sponsoring clinical trial NCT05726942?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05726942 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05726942's enrollment target sits among peer trials
30 99th of 115 higher than 16 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI